Tonghua Dongbao Pharmaceutical Co.,Ltd.’s Net Profit Dropped 59% in First Half of 2023

Tonghua Dongbao Pharmaceutical Co.,Ltd. (通化东宝药业股份有限公司) (600867.SH) reported a net profit of 485.1 million yuan in the first half of 2023, down 59% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, down 1.5% year-on-year.

At the end of the reporting period, it had 6.8 billion yuan in total assets and 300.4 million yuan in total liabilities, with a liability-to-asset ratio of 4.4%.